Skip to main content
OpenTrials

Clinical trial condition

Primary Progressive Multiple Sclerosis

Explore clinical trials studying Primary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Progressive Multiple Sclerosis trial results

Completed

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

NCT04458051

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • UC San Diego ACTRI Site Number : 8400101 La Jolla, California, United States
  • Collaborative Neuroscience Research Site Number : 8400045 Los Alamitos, California, United States
  • Multiple Sclerosis Center- Site Number : 8400143 Los Angeles, California, United States
  • Multiple Sclerosis Center of California Site Number : 8400135 Newport Beach, California, United States
View all 277 locations
View Trial Details
Completed

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

NCT05232825

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Neurology Associates PA Maitland, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis Owosso, Michigan, United States
View all 37 locations
View Trial Details

Related conditions